Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Cooper

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2019
Protective Immunity and New Vaccines for Lyme DiseaseMaria Gomes-Solecki, Paul M Arnaboldi, P Bryon Backenson, et al.
Ebiomedicine|August 1, 2022
Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimeraAmy S Espeseth, Maoli Yuan, Michael Citron, et al.
The Lancet. Infectious Diseases|June 22, 2020
Recent successes in therapeutics for Ebola virus disease: no time for complacencyPatrick L Iversen, Christopher D Kane, Xiankun Zeng, et al.
Ebiomedicine|March 29, 2025
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trialsChristopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2019
Protective Immunity and New Vaccines for Lyme DiseaseMaria Gomes-Solecki, Paul M Arnaboldi, P Bryon Backenson, et al.
Ebiomedicine|August 1, 2022
Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimeraAmy S Espeseth, Maoli Yuan, Michael Citron, et al.
The Lancet. Infectious Diseases|June 22, 2020
Recent successes in therapeutics for Ebola virus disease: no time for complacencyPatrick L Iversen, Christopher D Kane, Xiankun Zeng, et al.
Ebiomedicine|March 29, 2025
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trialsChristopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
Pageof 4